Because our previous work revealed that lymphoma stroma-derived B-cell activating factor (BAFF) confers stroma-mediated protection of MCL cells from therapy-induced apoptosis21, we examined whether BAFF also activates the BCR pathway. This evidence concerns the gene TNFSF13B and lymphoma.